Cerci JJ et al. 2012 |
Metabolic staging with PET (FDG-PET) |
Conventional staging
|
2010 |
Surgery avoided Susceptible individuals detected |
CCA |
NA |
NA |
NA |
NA |
Favourable |
Koenig A et al. 2010 |
Protocol for the early detection of sepsis |
No protocol |
2006 |
Years of productive life lost |
CCA |
NA |
NA |
NA |
NA |
Favourable |
Andrade MV et al. 2011 |
Electrocardiogram by telecardiology |
Electrocardiogram by referral to another municipality |
2008 |
Costs avoided for transport, food, tests and medical appointments |
CBA |
NI |
NI |
BCR positive |
NA |
Favourable |
Araújo DV et al. 2008 |
B-type natriuretic peptide |
Clinical judgment |
NI |
Hospitalization avoided Echocardiogram avoided |
CEA |
60 days |
NI |
Dominant |
< 1 GDP per capita |
Favourable |
Barreto AMEC et al. 2008 |
Algorithms A and B for the diagnosis of hepatitis C virus
|
Algorithm C (Conventional algorithm)
|
NI |
Concordance of results/Diagnostic performance |
CCA |
NA |
NA |
NA |
NA |
Neutral |
Bocchi EA et al. 1997 |
Gallium-67 cardiac scintigraphy |
Endomyocardial biopsies |
NI |
One-year survival, number of ndomyocardial biopsies/patient, treated rejection episodes, tricuspid regurgitation |
CCA |
NA |
NA |
NA |
NA |
Neutral |
Camelo Jr JS et al. 2009 |
Neonatal screening for galactosaemia |
No screening |
NI |
Medical care avoided Improved quality of life |
CBA |
NI |
NI |
BCR:1,04 |
NA |
Favourable |
Cerci JJ et al. 2011 |
FDG-PET |
Conventional clinical staging methods, including CT, bone marrow biopsy (BMB), and laboratory tests |
2009 |
Modified treatment case |
CEA |
NI |
NI |
$16,215 |
1 to 3 GDP per capita |
Favourable |
Cerci JJ et al. 2010 |
FDG-PET + CT + Biopsy |
CT + Biopsy |
2008 |
True case detected |
CEA BIA |
NI |
NI |
Dominant (-$3,268) |
< 1 GDP per capita |
Favourable |
Bertoldi EG et al. 2012 |
Annual echocardiogram for all patients Echocardiogram for patients with abnormal levels of B-type natriuretic peptide |
No screening No screening |
NI |
Diagnosis of cardiotoxicity |
CEA |
NI |
NI |
Private sector perspective US$19,925.64 to US$30,951.53 Public Sector perspective US$7,668.00 to US$20,232.87 |
1 to 3 GDP per capita < 1 GDP per capita |
Neutral |
Oliveira MRF et al. 2010 |
Optimal ¯ RDT for malaria |
Thick smear microscopy |
2006 |
Cases properly diagnosed |
CEA |
1 year |
Yes |
US$549.9 |
< 1 GDP per capita |
Unfavourable |
Oliveira MRF et al. 2012 |
RDTs for malaria |
Thick smear microscopy |
2010 |
Cases diagnosed |
CEA |
1 year |
NI |
US$44.77 |
< 1 GDP per capita |
Neutral |
Dowdy DW et al. 2008 |
Sputum smear microscopy |
Sputum smear microscopy + solid media or liquid media with MGIT |
2006 |
DALY avoided Case avoided |
CUA |
Lifetime |
Yes |
US$962 |
< 1 PIB per capita |
Favourable |
Oliveira MHP et al. 1983 |
Self-clean before urine collection |
Aseptic technique made by the nursing professional |
1982 |
Resultado microbiológico |
CMA |
NI |
NI |
NI |
NA |
Favourable |
Laranjeira FO et al. 2012 |
Portable monitors of glycated haemoglobin A1c |
Conventional laboratory test |
2011 |
Complications avoided |
CEA BIA |
Lifetime |
Yes |
Dominant |
< 1 GDP per capita |
Favourable |
Nomelini Rs et al. 2012 |
PCR for detecting HPV 16/18 |
Single probe-based PCR |
NI |
HPV and cervical lesions detected |
CCA |
NA |
NA |
NA |
NA |
Favourable |
Pang LW et al. 2001 |
New malaria management program (community-based diagnosis and treatment) |
Old malaria management program (central laboratory visits) |
NI |
NI |
CMA CBA |
1 year |
Yes |
BCR=9:1 Net savings: $60,900 |
NA |
Favourable |
Scherer LC et al. 2009 |
AFB smear used with PCR dot blot |
AFB smear used with culture |
NI |
Case correctly diagnosed |
CEA |
NI |
NI |
US$13,749 |
1 to 3 GDP per capita |
Neutral |
Silva LK 2003 |
Bone densitometry, + alendronate sodium or Bone densitometry, + hormone therapy or Hormone therapy or Calcium replacement + vitamin D |
Traditional care |
NI |
Femur fracture avoided |
CEA |
NI |
NI |
R$12.408 |
> 3 GDP per capita |
Unfavourable |
Vanni T et al. 2011 |
Strategy A
|
Strategies B, C, D and E
|
2008 |
Life years saved |
CEA |
Lifetime |
Yes |
US$10,303.54 |
1 to 3 GDP per capita |
Favourable |
Ward LS et al. 1993 |
Fine needle aspiration cytology |
Scintigraphy |
NI |
Surgery avoided |
CBA |
NI |
NI |
Public sector perspective BCR= 10.3 Private sector perspective BCR=8.5 |
NA |
Favourable |
Guerra RL et al. 2013 |
Strategy E1
|
Strategies E2 and E3
|
2012 |
Correct diagnosis |
CEA |
NI |
NI |
US$56.69 |
NI |
Favourable |
Steffen RE et al. 2013 |
QFT-GIT Or Tuberculin skin test followed by QFT-GIT |
Tuberculin skin test |
2010 |
Case avoided |
CEA |
2 years |
Yes |
US$16,021 |
1 to 3 GDP per capita |
Favourable |
Rosa RCM et al. 2012 |
Screening with abdominal ultrasound |
No screening |
NI |
Case identified |
CCA |
NA |
NA |
NA |
NA |
Favourable |